ASRT Stock Analysis: Buy, Sell, or Hold?
ASRT - Assertio Holdings, Inc. Common Stock
$23.50
0.02 (0.09%)
â˛
5d:
+0.3%
30d:
+0.77%
90d:
+99.66%
WAIT
LOW Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When ASRT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ASRT is fairly priced but lacks strong directional signals. At 9.0% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ASRT is fairly priced but lacks strong directional signals. At 9.0% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$25.31
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$15.71
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ASRT is currently trading at $23.50, which is considered fair based on recent price action. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.1) compared to its historical average (7.0). At these levels, the market is pricing in 9.0% annual earnings growth.
Technical Outlook: Technically, ASRT is in a strong uptrend. The price is currently testing key support at $23.41. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ASRT is in a strong uptrend. The price is currently testing key support at $23.41. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
49/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
66.2%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- NEUTRAL: Near Wall St target ($24.43)
- BULLISH: Expecting earnings turnaround to 9.0% growth with -62.5% revenue growth
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$23.41
Resistance Level
$23.50
Current Trend
Strong Uptrend
Technical data as of
Jun 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.11
Wall Street Target
$24.43
(+4.0%)
Revenue Growth (YoY)
-62.5%
Earnings Growth (YoY)
-18.8%
Profit Margin
-34.9%
Valuation Premium vs History
+9.0% premium
PE vs Historical
9.1 vs 7.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.0%
(market-implied from PE analysis)
1-Year Target
$25.62
(+9%)
2-Year Target
$27.92
(+19%)
3-Year Target
$30.43
(+30%)
3-Yr Target (if PE normalizes)
(PE: 9â7)
PE COMPRESSION
$23.39
(-1%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: August 24, 2026 5:57 PM ET
Data refreshes hourly during market hours. Next update: 6:57 PM
Data refreshes hourly during market hours. Next update: 6:57 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ASRT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences IâĻ |
STRONG BUY
25 analysts |
$212 | 67 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$107 | 54 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$101 | 50 HOLD |
|
UTHR
United Therapeutics CorpâĻ |
STRONG BUY
15 analysts |
$664 | 49 HOLD |
|
BCRX
BioCryst PharmaceuticalsâĻ |
STRONG BUY
12 analysts |
$21 | 50 HOLD |
